Dermal Phototoxicity Study

Status:
Completed

Trial end date:
2016-10-01

Target enrollment:

Participant gender:

Dermal Safety study to determine the Phototoxicity Potential of FMX-101 4% in Healthy Volunteers

Phase 1

Foamix Ltd.
Vyne Therapeutics Inc.

Minocycline